Ranked #1,733 of 8,699 institutional investors
Nantahala Capital Management, LLC
New Canaan, CT
$1.60B
US stock portfolio at live prices · today −$28.9M (−1.77%)
Live prices, last trade 12:14 PM ET
- Value at quarter end (Q3 2026)
- $1.77B
- Change from Q2 2026
- −$1.52B (−46.08%)
- Positions
- 121 · 23 new, 10 sold out
- Filed
- Nov 13, 2026
Not counted in the ranking: call options on $531M of stock, put options on $852M, $4.8M of convertible notes and other principal-amount securities. $156M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesTBBK 4.05%BVS 3.98%HGV 3.53%ETON 3.29%PTON 2.88%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| TBBK The Bancorp, Inc. | 1,465,277 | $64.9M | 4.05% | Reduced −41% |
| BVS Bioventus Inc. | 6,420,884 | $63.8M | 3.98% | Reduced −46% |
| HGV Hilton Grand Vacations Inc. | 1,276,542 | $56.6M | 3.53% | Reduced −38% |
| ETON Eton Pharmaceuticals, Inc. | 875,507 | $52.8M | 3.29% | Reduced −63% |
| PTON Peloton Interactive, Inc. | 9,044,435 | $46.3M | 2.88% | Reduced −11% |
| AMRX Amneal Pharmaceuticals, Inc. | 2,115,749 | $44.6M | 2.78% | Reduced −53% |
| EOLS Evolus, Inc. | 6,244,690 | $42.8M | 2.67% | Reduced −44% |
| LBRX LB Pharmaceuticals Inc | 1,074,374 | $41.6M | 2.59% | Reduced −49% |
| FOSL Fossil Group, Inc. | 5,505,128 | $39.1M | 2.44% | Reduced −50% |
| RARE Ultragenyx Pharmaceutical Inc. | 2,339,293 | $38.8M | 2.42% | New |
| ADMA ADMA Biologics, Inc. | 2,590,475 | $34.2M | 2.14% | Reduced −45% |
| SVRA Savara Inc. | 7,137,159 | $30.8M | 1.92% | Reduced −49% |
| REGN Regeneron Pharmaceuticals, Inc. | 31,141 | $29.0M | 1.81% | New |
| GOGO Gogo Inc. | 11,214,792 | $28.8M | 1.80% | Reduced −36% |
| AURA Aura Biosciences, Inc. | 3,807,300 | $26.1M | 1.63% | Reduced −35% |
| DSGR Distribution Solutions Group, Inc. | 733,684 | $25.7M | 1.60% | Reduced −26% |
| FULC Fulcrum Therapeutics, Inc. | 6,575,352 | $24.3M | 1.52% | Reduced −40% |
| JACK Jack in the Box Inc. | 1,730,659 | $23.5M | 1.46% | Reduced −50% |
| FOXF Fox Factory Holding Corp. | 1,403,584 | $23.1M | 1.44% | Reduced −46% |
| SLN Silence Therapeutics plc | 1,162,384 | $23.0M | 1.44% | Reduced −57% |
| TITN Titan Machinery Inc. | 1,137,589 | $23.0M | 1.44% | Reduced −50% |
| MDXG MiMedx Group, Inc. | 6,910,564 | $21.2M | 1.33% | Reduced −28% |
| PLNT Planet Fitness, Inc. | 343,638 | $20.5M | 1.28% | Reduced −38% |
| RMR The RMR Group Inc. | 1,252,827 | $20.1M | 1.26% | Reduced −45% |
| VOR Vor Biopharma Inc. | 931,644 | $18.4M | 1.15% | Reduced −45% |
| IRD Opus Genetics, Inc. | 4,569,528 | $18.0M | 1.12% | Reduced −25% |
| ZVRA Zevra Therapeutics, Inc. | 1,963,096 | $17.4M | 1.09% | Reduced −45% |
| JCAP Jefferson Capital, Inc. | 825,607 | $17.3M | 1.08% | Reduced −45% |
| KROS Keros Therapeutics, Inc. | 1,490,051 | $16.9M | 1.05% | Reduced −47% |
| INSP Inspire Medical Systems, Inc. | 293,034 | $16.2M | 1.01% | Reduced −46% |
| TNGX Tango Therapeutics, Inc. | 707,136 | $15.6M | 0.97% | Reduced −29% |
| BCRX BioCryst Pharmaceuticals, Inc. | 2,101,257 | $15.3M | 0.95% | Reduced −45% |
| XTNT Xtant Medical Holdings, Inc. | 68,394,000 | $15.0M | 0.94% | Reduced −50% |
| RDNW RideNow Group, Inc. | 3,436,607 | $14.9M | 0.93% | Reduced −47% |
| ABVX ABIVAX Société Anonyme | 198,745 | $14.7M | 0.91% | Reduced −26% |
| AVTX Avalo Therapeutics, Inc. | 2,142,308 | $14.5M | 0.90% | Reduced −42% |
| OBX Obsidian Therapeutics, Inc. | 1,199,796 | $14.4M | 0.90% | New |
| AVR Anteris Technologies Global Corp. | 2,759,807 | $13.7M | 0.85% | Reduced −59% |
| BNTC Benitec Biopharma Inc. | 1,677,567 | $13.5M | 0.84% | Reduced −44% |
| ABEO Abeona Therapeutics Inc. | 5,410,643 | $13.4M | 0.84% | Reduced −47% |
| PCVX Vaxcyte, Inc. | 231,446 | $13.1M | 0.82% | Reduced −48% |
| USNA USANA Health Sciences, Inc. | 988,543 | $12.9M | 0.80% | Reduced −39% |
| GERN Geron Corporation | 13,873,533 | $12.6M | 0.79% | Reduced −43% |
| CWH Camping World Holdings, Inc. | 2,977,606 | $12.5M | 0.78% | Reduced −42% |
| VSTM Verastem, Inc. | 1,779,840 | $11.7M | 0.73% | Reduced −75% |
| RYAM Rayonier Advanced Materials Inc. | 2,236,017 | $10.6M | 0.66% | Reduced −34% |
| ALEC Alector, Inc. | 4,318,109 | $10.2M | 0.63% | Reduced −50% |
| AGMB AgomAb Therapeutics NV | 1,747,770 | $10.0M | 0.63% | Reduced −44% |
| IVA Inventiva S.A. | 3,004,859 | $9.8M | 0.61% | Reduced −44% |
| RSVR Reservoir Media, Inc. | 952,955 | $9.7M | 0.60% | Reduced −49% |
| MLYS Mineralys Therapeutics, Inc. | 689,841 | $9.7M | 0.60% | Reduced −58% |
| DHX DHI Group, Inc. | 2,491,945 | $9.6M | 0.60% | Reduced −48% |
| IWM iShares Russell 2000 ETF | 34,449 | $8.9M | 0.56% | New |
| JANX Janux Therapeutics, Inc. | 857,334 | $8.9M | 0.55% | Reduced −47% |
| KRRO Korro Bio, Inc. | 680,246 | $8.4M | 0.53% | Reduced −48% |
| ATTO Attovia Therapeutics, Inc. | 561,180 | $8.3M | 0.52% | New |
| APYX Apyx Medical Corporation | 3,343,353 | $8.0M | 0.50% | Reduced −49% |
| KIDS OrthoPediatrics Corp. | 242,342 | $7.8M | 0.49% | Reduced −50% |
| SVC Service Properties Trust | 1,386,791 | $7.5M | 0.46% | New |
| XFOR X4 Pharmaceuticals, Inc. | 2,449,468 | $7.3M | 0.46% | Reduced −50% |
| IMAX IMAX Corporation | 151,497 | $7.1M | 0.44% | Reduced −88% |
| ZLAB Zai Lab Limited | 330,000 | $6.8M | 0.43% | Reduced −18% |
| FLWS 1-800-FLOWERS.COM, Inc. | 3,375,065 | $6.7M | 0.42% | Reduced −50% |
| GLUE Monte Rosa Therapeutics, Inc. | 721,064 | $6.3M | 0.39% | Reduced −45% |
| VMD Viemed Healthcare, Inc. | 714,674 | $6.1M | 0.38% | Reduced −43% |
| DYN Dyne Therapeutics, Inc. | 382,438 | $6.0M | 0.38% | New |
| COOK Traeger, Inc. | 109,266 | $6.0M | 0.37% | Reduced −34% |
| DUOL Duolingo, Inc. | 40,328 | $5.9M | 0.37% | Reduced −76% |
| DKS DICK'S Sporting Goods, Inc. | 40,000 | $5.4M | 0.33% | New |
| ILPT Industrial Logistics Properties Trust | 876,153 | $4.9M | 0.30% | Reduced −61% |
| UNCY Unicycive Therapeutics, Inc. | 1,401,448 | $4.9M | 0.30% | Reduced −50% |
| NDLS Noodles & Company | 554,246 | $4.7M | 0.29% | Reduced −50% |
| TELA TELA Bio, Inc. | 6,545,596 | $4.6M | 0.29% | Reduced −44% |
| ELOX Eloxx Pharmaceuticals, Inc. | 400,000 | $4.3M | 0.27% | Reduced −50% |
| SGMT Sagimet Biosciences Inc. | 471,831 | $4.3M | 0.27% | New |
| LXEO Lexeo Therapeutics, Inc. | 1,300,000 | $4.1M | 0.26% | Reduced −50% |
| FORR Forrester Research, Inc. | 413,046 | $3.7M | 0.23% | Reduced −73% |
| ALTG Alta Equipment Group Inc. | 791,839 | $3.6M | 0.22% | Reduced −45% |
| PAYO Payoneer Global Inc. | 483,836 | $3.5M | 0.22% | Reduced −50% |
| RDI Reading International, Inc. | 2,029,466 | $3.5M | 0.22% | Reduced −47% |
| AYTU Aytu BioPharma, Inc. | 1,086,812 | $2.9M | 0.18% | Reduced −50% |
| ELUT Elutia Inc. | 3,184,947 | $2.6M | 0.16% | Reduced −50% |
| CDXS Codexis, Inc. | 2,597,869 | $2.6M | 0.16% | Reduced −64% |
| VTRS Viatris Inc. | 133,005 | $2.6M | 0.16% | New |
| TLPH Talphera, Inc. | 3,492,519 | $2.6M | 0.16% | Reduced −50% |
| IKT Inhibikase Therapeutics, Inc. | 1,951,863 | $2.5M | 0.16% | Reduced −64% |
| STKS The ONE Group Hospitality, Inc. | 2,139,182 | $2.3M | 0.15% | Reduced −50% |
| ALT Altimmune, Inc. | 1,720,000 | $2.3M | 0.15% | Reduced −43% |
| WING Wingstop Inc. | 14,800 | $2.3M | 0.14% | New |
| ARVN Arvinas, Inc. | 300,000 | $1.9M | 0.12% | Reduced −50% |
| CATX Perspective Therapeutics, Inc. | 2,492,642 | $1.9M | 0.12% | Reduced −46% |
| NSPR InspireMD, Inc. | 3,376,484 | $1.8M | 0.11% | Reduced −50% |
| IMUX Immunic, Inc. | 250,646 | $1.8M | 0.11% | Reduced −50% |
| DXLG Destination XL Group, Inc. | 4,658,915 | $1.8M | 0.11% | Reduced −44% |
| KLRA Kailera Therapeutics, Inc. | 140,000 | $1.6M | <0.1% | Reduced −50% |
| VENU Venu Holding Corp | 1,546,705 | $1.6M | <0.1% | Reduced −50% |
| EDIT Editas Medicine, Inc. | 852,700 | $1.5M | <0.1% | Reduced −50% |
| ACU Acme United Corporation | 20,427 | $1.4M | <0.1% | Reduced −50% |
| DRIO DarioHealth Corp. | 978,340 | $1.3M | <0.1% | Reduced −20% |
| GAIA Gaia, Inc. | 974,138 | $1.2M | <0.1% | Reduced −47% |
| TLSI TriSalus Life Sciences, Inc. | 500,000 | $1.2M | <0.1% | Reduced −75% |
| POCI Precision Optics Corporation, Inc. | 280,000 | $1.2M | <0.1% | Reduced −50% |
| ARTV Artiva Biotherapeutics, Inc. | 300,000 | $1.1M | <0.1% | Reduced −50% |
| BRCC BRC Inc. | 137,280 | $1.1M | <0.1% | New |
| FEMY Femasys Inc. | 802,145 | $987K | <0.1% | New |
| HAIN The Hain Celestial Group, Inc. | 8,528,789 | $913K | <0.1% | Reduced −50% |
| QNRX Quoin Pharmaceuticals, Ltd. | 236,234 | $823K | <0.1% | New |
| AKBA Akebia Therapeutics, Inc. | 2,000,000 | $814K | <0.1% | Reduced −50% |
| GRCE Grace Therapeutics, Inc. | 476,190 | $803K | <0.1% | New |
| EHTH eHealth, Inc. | 1,761,441 | $574K | <0.1% | Reduced −50% |
| GUTS Fractyl Health, Inc. | 621,522 | $561K | <0.1% | New |
| AEON AEON Biopharma, Inc. | 4,400,000 | $552K | <0.1% | New |
| YARW Yarrow Bioscience, Inc. | 39,198 | $521K | <0.1% | New |
| CRMT America's Car-Mart, Inc. | 644,686 | $511K | <0.1% | Reduced −50% |
| PASG Passage Bio, Inc. | 127,370 | $483K | <0.1% | New |
| CUE Cue Biopharma, Inc. | 96,049 | $439K | <0.1% | New |
| MREO Mereo BioPharma Group plc | 1,255,610 | $337K | <0.1% | New |
| CLRB Cellectar Biosciences, Inc. | 219,998 | $177K | <0.1% | Reduced −50% |
| LSTA Lisata Therapeutics, Inc. | 101,221 | $90K | <0.1% | New |
| LONA LeonaBio, Inc. | 37,661 | $87K | <0.1% | New |
| APRE Aprea Therapeutics, Inc. | 205,760 | $56K | <0.1% | Reduced −50% |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| AMLX Amylyx Pharmaceuticals, Inc. | 973,368 | $25.2M |
| TRAX First Tracks Biotherapeutics, Inc. | 500,000 | $21.0M |
| CHYM Chime Financial, Inc. | 344,238 | $10.5M |
| RH RH | 73,372 | $8.1M |
| RLYB Rallybio Corporation | 376,844 | $5.7M |
| TRDA Entrada Therapeutics, Inc. | 601,150 | $2.7M |
| SNAP Snap Inc. | 400,000 | $1.9M |
| ALXO ALX Oncology Holdings Inc. | 1,500,000 | $1.6M |
| SGRP SPAR Group, Inc. | 1,321,376 | $542K |
| SNTI Senti Biosciences Holdings, Inc. | 26,909 | $67K |